Hostname: page-component-848d4c4894-jbqgn Total loading time: 0 Render date: 2024-06-16T01:41:07.263Z Has data issue: false hasContentIssue false

The influence of depressive symptoms on quality of life in coronary artery disease inpatients after the successful coronary angioplasty

Published online by Cambridge University Press:  16 April 2020

D. Dudek
Affiliation:
Department of Psychiatry, Collegium Medicum of Jagiellonian University, Kracow, Poland
W. Datka
Affiliation:
Department of Psychiatry, Collegium Medicum of Jagiellonian University, Kracow, Poland
M. Siwek
Affiliation:
Department of Psychiatry, Collegium Medicum of Jagiellonian University, Kracow, Poland
A. Wróbel
Affiliation:
Department of Psychiatry, Collegium Medicum of Jagiellonian University, Kracow, Poland
A. Zięba
Affiliation:
Department of Psychiatry, Collegium Medicum of Jagiellonian University, Kracow, Poland

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background:

Studies confirm a strong relationship between depression, quality of life and coronary artery disease (CAD)

Aim:

To assess how the comorbidity of depressive symptoms and CAD influences the quality of life (QoL) in patients after the successful coronary angioplasty (PCI).

Methods:

227 patients with CAD selected for PTCA were enrolled. 156 patients with full clinical and angiographic success and without restenosis within 4 weeks after the intervention were included in one year follow-up. Patients' status was assessed four times (one day before and at 1, 6 and 12 months after the intervention), with: polish version of SF-36, Beck Depression Inventory (BDI), Rosenberg Self-Esteem Scale (RS), Beck Hopelessness Scale (HS), Automatic Thoughts Questionnaire (ATQ).

Results:

In the whole study group (n=156) the QoL at 1 month after PTCA was significantly improved. This tendency persisted in further examinations. There was a significant correlation between the quality of life (SF-36), severity of depressive symptoms (BDI) and parameters describing depressive changes in thinking (HS, RS, ATQ). On each occasion during the one-year follow-up the presence of depressive symptoms was associated with the poorer quality of life, both with respect to the total SF-36 points and individual components of QoL measured by 8 subscales of the SF-36.

Conclusion:

Present findings indicate that depressive disorders in patients with CAD – even after successful intervention –significantly affect the quality of life. Optimized comprehensive approach to CAD patients with concomitant depressive disorders may require inclusion of psychological intervention, and in severe cases even psychiatric treatment.

Type
Poster Session 2: Depressive Disorders
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.